AbstractThe binding and intake of liposomes containing a different molar content and chain length of a PEG-Chol derivative had been studied in cultured macrophage cell line J774. The decrease in binding and endocytosis of the liposomes containing PEG-Chol is dependent on (i) the PEG chain length, (ii) the molar content of the surfactant, (iii) the liposome concentration in the external medium. The best results in reducing the uptake of liposomes were obtained by a PEG-Chol liposome suspension with a high molar content (25%) which presents a non negligible amount of free PEG-Chol. Moreover, we could show an increase by 2 for binding and by about 5 for endocytosis of filtrated-liposomes containing 25 mol% of 8800PEG-Chol, in the absence of fr...
AbstractIncorporation of 5 mol% poly(ethylene glycol)-conjugated lipids (PEG-lipids) has been shown ...
AbstractWe describe the synthesis of biodegradable poly(ethyleneglycol)-coupled galactolipids in whi...
Specific targeting of drugs to for instance tumors or sites of inflammation may be achieved by means...
AbstractA serious problem using liposomes for therapeutic purposes is the fast removal from blood ci...
AbstractThe incorporation of poly(ethylene glycol) (PEG)-conjugated lipids in lipid-based carriers s...
This thesis concerns the interactions experienced by liposomal drug delivery systems as they circul...
This thesis concerns the interactions experienced by liposomal drug delivery systems as they circul...
AbstractThe effect of poly(ethylene glycol) cholesteryl ethers (PEG(n)-Chols) with two different num...
AbstractMonolayers of dipalmitoyl-phosphatidylethanolamine (DPPE) mixing with various mole percentag...
The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior o...
AbstractThe incorporation of poly(ethylene glycol) (PEG)-conjugated lipids in lipid-based carriers s...
The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior o...
Strategies used to enhance liposome-mediated drug delivery in vivo include the enhancement of stabil...
AbstractIncorporation of dioleoyl N-(monomethoxy polyethyleneglycol succinyl)phosphotidylethanolamin...
Strategies used to enhance liposome-mediated drug delivery in vivo include the enhancement of stabil...
AbstractIncorporation of 5 mol% poly(ethylene glycol)-conjugated lipids (PEG-lipids) has been shown ...
AbstractWe describe the synthesis of biodegradable poly(ethyleneglycol)-coupled galactolipids in whi...
Specific targeting of drugs to for instance tumors or sites of inflammation may be achieved by means...
AbstractA serious problem using liposomes for therapeutic purposes is the fast removal from blood ci...
AbstractThe incorporation of poly(ethylene glycol) (PEG)-conjugated lipids in lipid-based carriers s...
This thesis concerns the interactions experienced by liposomal drug delivery systems as they circul...
This thesis concerns the interactions experienced by liposomal drug delivery systems as they circul...
AbstractThe effect of poly(ethylene glycol) cholesteryl ethers (PEG(n)-Chols) with two different num...
AbstractMonolayers of dipalmitoyl-phosphatidylethanolamine (DPPE) mixing with various mole percentag...
The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior o...
AbstractThe incorporation of poly(ethylene glycol) (PEG)-conjugated lipids in lipid-based carriers s...
The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior o...
Strategies used to enhance liposome-mediated drug delivery in vivo include the enhancement of stabil...
AbstractIncorporation of dioleoyl N-(monomethoxy polyethyleneglycol succinyl)phosphotidylethanolamin...
Strategies used to enhance liposome-mediated drug delivery in vivo include the enhancement of stabil...
AbstractIncorporation of 5 mol% poly(ethylene glycol)-conjugated lipids (PEG-lipids) has been shown ...
AbstractWe describe the synthesis of biodegradable poly(ethyleneglycol)-coupled galactolipids in whi...
Specific targeting of drugs to for instance tumors or sites of inflammation may be achieved by means...